Bone Marrow - Mesenchymal Stem Cell and Platelet Rich Fibrin: A Promising Step of Growth Plate Injury Treatment in Rabbit
Abstract
Background/Aim: Paediatric physeal injuries account for about 30 % of all bone injuries, often affecting growth plates. Current treatments emphasise prevention, as regenerating the damaged physis is challenging. This study aimed to analyse whether combining bone marrow mesenchymal stem-cell (BM-MSC) and platelet-rich fibrin (PRF) can regenerate physis bone.
Methods: The twenty-four New Zealand white rabbits, aged 6 weeks, were acclimatised for 1 week. BM-MSC and PRF were then prepared. A physis injury was induced in the proximal tibia of the rabbits, then divided into four groups: control, BM-MSC treatment, PRF treatment, combination of BM-MSC and PRF treatment. After 4 weeks, rabbits were sacrificed and evaluated. The bony bar diameter was measured using haematoxylin-eosin (H&E) staining, while the expression of tumour necrosis factor-alpha (TNF-α), vascular endothelial growth factor (VEGF) and SRY-box transcription factor 9 (SOX-9) was evaluated using immunohistochemistry (IHC).
Results: Histology showed that the BM-MSC and PRF combination led to better regeneration than the control, BM-MSC alone, or PRF alone in terms of osteochondral union. SOX-9 indicators showed significant differences between the control vs BM-MSC groups (p = 0.099); BM-SC vs PRF groups (p = 0.032). TNF-α indicators showed no significant differences at all. VEGF indicators showed significant differences between the control vs BM-MSC and PRF groups (p = 0.008); PRF vs BM-MSC and PRF groups (p = 0.021).
Conclusion: Administration of BM-MSC, PRF or a combination of BM-MSC and PRF showed comparable effectiveness in osteochondral union based on histological outcomes. Conversely, PRF alone exhibited the highest effectiveness in IHC analysis. However, none of these results were statistically significant.
References
Eastwood DM, de Gheldere A. Physeal injuries in children. Surgery (Oxford). 2011;29(4):146–52. doi: 10.1016/j.mpsur.2011.01.003.
Salzmann GM, Niemeyer P, Hochrein A, Stoddart MJ, Angele P. Articular cartilage repair of the knee in children and adolescents. Orthop J Sports Med. 2018;6(3):232596711876019. doi: 10.1177/2325967118760190.
Vasanthan J, Gurusamy N, Rajasingh S, Sigamani V, Kirankumar S, Thomas EL, et al. Role of human mesenchymal stem cells in regenerative therapy. Cells. 2020;10(1):54. doi: 10.3390/cells10010054.
Chung R, Foster BK, Xian CJ. Preclinical studies on mesenchymal stem cell-based therapy for growth plate cartilage injury repair. Stem Cells Int. 2011;2011:1–10. doi: 10.4061/2011/570125.
Tjempakasari A, Suroto H, Santoso D. Mesenchymal stem cell senescence and osteogenesis. Medicina (B Aires). 2021;58(1):61. doi: 10.3390/medicina58010061.
Utomo DN, Widiastana IGA. The effect platelet rich plasma on mesenchymal stem cells (MSCs) differentation into chondroblast. J Orthop Traumatol Surabaya. 2019;6(2):80. doi: 10.20473/joints.v6i2.2017.80-85.
Shaw N, Erickson C, Bryant SJ, Ferguson VL, Krebs MD, Hadley-Miller N, et al. Regenerative medicine approaches for the treatment of pediatric physeal injuries. Tissue Eng Part B Rev. 2018;24(2):85–97. doi: 10.1089/ten.teb.2017.0274.
Watanabe H, Maishi N, Hoshi-Numahata M, Nishiura M, Nakanishi-Kimura A, Hida K, et al. Skeletal-vascular interactions in bone development, homeostasis, and pathological destruction. Int J Mol Sci. 2023;24(13):10912. doi: 10.3390/ijms241310912.
Hu K, Olsen BR. The roles of vascular endothelial growth factor in bone repair and regeneration. Bone. 2016;91:30–8. doi: 10.1016/j.bone.2016.06.013.
Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets. 2018;29(1):48–55. doi: 10.1080/09537104.2017.1293807.
Yu Y, Rodriguez-Fontan F, Eckstein K, Muralidharan A, Uzcategui AC, Fuchs JR, et al. Rabbit model of physeal injury for the evaluation of regenerative medicine approaches. Tissue Eng Part C Methods. 2019;25(12):701–10. doi: 10.1089/ten.tec.2019.0180.
Yin N, Wang Y, Ding L, Yuan J, Du L, Zhu Z, et al. Platelet-rich plasma enhances the repair capacity of muscle-derived mesenchymal stem cells to large humeral bone defect in rabbits. Sci Rep. 2020;10(1):6771. doi: 10.1038/s41598-020-63496-5.
Wong KL, Zhang S, Tan SSH, Cheow YA, Lai RC, Lim SK, et al. Mesenchymal stem cell exosomes promote growth plate repair and reduce limb-length discrepancy in young rats. J Bone Joint Surg. 2022;104(12):1098–106. doi: 10.2106/JBJS.21.00789.
Guo R, Zhuang H, Chen X, Ben Y, Fan M, Wang Y, et al. Tissue engineering in growth plate cartilage regeneration: Mechanisms to therapeutic strategies. J Tissue Eng. 2023;14:20417314231187956. doi: 10.1177/20417314231187956.
Kim J, Ha Y, Kang NH. Effects of growth factors from platelet-rich fibrin on the bone regeneration. J Craniofac Surg. 2017;28(4):860–5. doi: 10.1097/SCS.0000000000003396.
Barbon S, Stocco E, Macchi V, Contran M, Grandi F, Borean A, et al. Platelet-rich fibrin scaffolds for cartilage and tendon regenerative medicine: from bench to bedside. Int J Mol Sci. 2019;20(7):1701. doi: 10.3390/ijms20071701.
Hidajat NN, Mulyadi D, Chaidir MR, Dewangga TH. Platelet-rich fibrin enhances fracture healing in tibial long bone: an experiment in rabbit. Althea Med J. 2020;7(4). doi: 10.15850/amj.v7n4.1960.
Utomo DN, Hernugrahanto KD. The role of platelet-rich fibrin facilitates the healing of gastrocnemius muscle defect: a preliminary study on animal model. (JOINTS) J Orthop Traumatol Surabaya. 2019;7(1):31. doi: 10.20473/joints.v7i1.2018.31-41.
Utomo DN, Mahyudin F, Hernugrahanto KD, Suroto H, Chilmi MZ, Rantam FA. Implantation of platelet rich fibrin and allogenic mesenchymal stem cells facilitate the healing of muscle injury: An experimental study on animal. Int J Surg Open. 2018;11:4–9. doi: 10.1016/j.ijso.2018.03.001.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).